Inhibition of Histone Deacetylase Activity by Butyrate
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hinnebusch, 2002, The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation, J. Nutr, 132, 1012, 10.1093/jn/132.5.1012
Emenaker, 2001, Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model, J. Nutr, 131, 3041S, 10.1093/jn/131.11.3041S
Sun, 2001, Effect of estradiol on histone acetylation dynamics in human breast cancer cells, J. Biol. Chem, 276, 49435, 10.1074/jbc.M108364200
Hendzel, 1991, Histone deacetylase is a component of the internal nuclear matrix, J. Biol. Chem, 266, 21936, 10.1016/S0021-9258(18)54727-X
Covault, 1980, The identification of distinct populations of acetylated histone, J. Biol. Chem, 255, 9110, 10.1016/S0021-9258(19)70534-1
Zhang, 1988, Histone acetylation in chicken erythrocytes: rates of acetylation and evidence that histones in both active and potentially active chromatin are rapidly modified, Biochem. J, 250, 233, 10.1042/bj2500233
Sun, 2002, The transcriptional repressor Sp3 is associated with CK2 phosphorylated histone deacetylase 2, J. Biol. Chem, 277, 35783, 10.1074/jbc.C200378200
Prasad, 1976, Effect of sodium butyrate on mammalian cells in culture: a review, In Vitro, 12, 125, 10.1007/BF02796360
Leder, 1975, Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells, Cell, 5, 319, 10.1016/0092-8674(75)90107-5
Riggs, 1977, n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells, Nature, 268, 462, 10.1038/268462a0
Candido, 1978, Sodium butyrate inhibits histone deacetylation in cultured cells, Cell, 14, 105, 10.1016/0092-8674(78)90305-7
Sealy, 1978, The effect of sodium butyrate on histone modification, Cell, 14, 115, 10.1016/0092-8674(78)90306-9
Boffa, 1978, Suppression of histone deacetylation in vivo and in vitro by sodium butyrate, J. Biol. Chem, 253, 3364, 10.1016/S0021-9258(17)34804-4
Vidali, 1978, Suppression of histone deacetylation by butyrate leads to accumulation of multi-acetylated forms of histones H3 and H4 and increased DNase I-sensitivity of the associated DNA sequences, Proc. Natl. Acad. Sci. U.S.A, 75, 2239, 10.1073/pnas.75.5.2239
Luger, 1997, Crystal structure of the nucleosome core particle at 2.8 A resolution, Nature, 389, 251, 10.1038/38444
Luger, 1998, The histone tails of the nucleosome, Curr. Opin. Genet. Dev, 8, 140, 10.1016/S0959-437X(98)80134-2
Spencer, 1999, Role of covalent modifications of histones in regulating gene expression, Gene, 240, 1, 10.1016/S0378-1119(99)00405-9
Pogo, 1966, RNA synthesis and histone acetylation during the course of gene activation in lymphocytes, Proc. Natl. Acad. Sci. U.S.A, 55, 805, 10.1073/pnas.55.4.805
Garcia-Ramirez, 1995, Modulation of chromatin folding by histone acetylation, J. Biol. Chem, 270, 17923, 10.1074/jbc.270.30.17923
Wang, 2001, Effects of histone acetylation on the solubility and folding of the chromatin fiber, J. Biol. Chem, 276, 12764, 10.1074/jbc.M100501200
Tse, 1998, Disruption of higher order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III, Mol. Cell. Biol, 18, 4629, 10.1128/MCB.18.8.4629
Hansen, 1998, Structure and function of the core histone N-termini: more than meets the eye, Biochemistry, 37, 17637, 10.1021/bi982409v
Wang, 2000, Acetylation increases the alpha-helical content of the histone tails of the nucleosome, J. Biol. Chem, 275, 35013, 10.1074/jbc.M004998200
Nightingale, 1998, Histone acetylation facilitates RNA polymerase II transcription of the drosophila hsp26 gene in chromatin, EMBO J, 17, 2865, 10.1093/emboj/17.10.2865
Davie, 2000, Control of chromatin remodeling, Crit. Rev. Eukaryot. Gene Expr, 10, 303, 10.1615/CritRevEukarGeneExpr.v10.i3-4.70
Sterner, 2000, Acetylation of histones and transcription-related factors, Microbiol. Mol. Biol. Rev, 64, 435, 10.1128/MMBR.64.2.435-459.2000
Fischle, 1999, A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p, J. Biol. Chem, 274, 11713, 10.1074/jbc.274.17.11713
Grozinger, 1999, Three proteins define a class of human histone deacetylases related to yeast Hda1p, Proc. Natl. Acad. Sci. U.S.A, 96, 4868, 10.1073/pnas.96.9.4868
Fischle, 2001, The emerging role of class II histone deacetylases, Biochem. Cell Biol, 79, 337, 10.1139/o01-116
Grozinger, 2002, Deacetylase enzymes: biological functions and the use of small-molecule inhibitors, Chem. Biol, 9, 3, 10.1016/S1074-5521(02)00092-3
Guardiola, 2002, Molecular cloning and characterization of a novel histone deacetylase HDAC10, J. Biol. Chem, 277, 3350, 10.1074/jbc.M109861200
Kao, 2002, Isolation and characterization of mammalian HDAC10, a novel histone deacetylase, J. Biol. Chem, 277, 187, 10.1074/jbc.M108931200
Herrera, 1999, Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes, Mol. Cell. Biol, 19, 3466, 10.1128/MCB.19.5.3466
Munshi, 1998, Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome, Mol. Cell, 2, 457, 10.1016/S1097-2765(00)80145-8
Sterner, 1979, Studies of acetylation and deacetylation in high mobility group proteins: identification of the sites of acetylation in HMG 1, J. Biol. Chem, 254, 11577, 10.1016/S0021-9258(19)86524-9
Braun, 2001, Transcription factor Sp3 is regulated by acetylation, Nucleic Acids Res, 29, 4994, 10.1093/nar/29.24.4994
Cheung, 2000, Acetylation and chromosomal functions, Curr. Opin. Cell Biol, 12, 326, 10.1016/S0955-0674(00)00096-X
Berger, 1999, Gene activation by histone and factor acetyltransferases, Curr. Opin. Cell Biol, 11, 336, 10.1016/S0955-0674(99)80046-5
Davie, 1997, Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin, Mol. Biol. Rep, 24, 197, 10.1023/A:1006811817247
Wu, 1986, Histones and their modifications, CRC Crit. Rev. Biochem, 20, 201, 10.3109/10409238609083735
Spencer, 2001, Dynamically acetylated histone association with transcriptionally active and competent genes in the avian adult β-globin gene domain, J. Biol. Chem, 276, 34810, 10.1074/jbc.M104886200
Perry, 1982, Histone acetylation increases the solubility of chromatin and occurs sequentially over most of the chromatin. A novel model for the biological role of histone acetylation, J. Biol. Chem, 257, 7336, 10.1016/S0021-9258(18)34382-5
Finnin, 1999, Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors, Nature, 401, 188, 10.1038/43710
Cousens, 1979, Different accessibilities in chromatin to histone acetylase, J. Biol. Chem, 254, 1716, 10.1016/S0021-9258(17)37831-6
Ayer, 1999, Histone deacetylases: transcriptional repression with SINers and NuRDs, Trends Cell Biol, 9, 193, 10.1016/S0962-8924(99)01536-6
Knoepfler, 1999, Sin meets NuRD and other tails of repression, Cell, 99, 447, 10.1016/S0092-8674(00)81531-7
Gray, S. G. & Teh, B. T. (2001) Histone acetylation/deacetylation and cancer: an ‘‘open’’ and ‘‘shut’’ case? Curr. Mol. Med. 1: 401–429.
Shang, 2000, Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription, Cell, 103, 843, 10.1016/S0092-8674(00)00188-4
Hart, 2002, The estrogen receptor: more than the average transcription factor, Biochem. Cell Biol, 80, 335, 10.1139/o02-038
Ghosh, 1999, Regulation of inducible gene expression by the transcription factor NF-kappaB, Immunol. Res, 19, 183, 10.1007/BF02786486
Zhong, 2002, The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1, Mol. Cell, 9, 625, 10.1016/S1097-2765(02)00477-X
Kruh, 1982, Effects of sodium butyrate, a new pharmacological agent, on cells in culture, Mol. Cell. Biochem, 42, 65
Van Lint, 1996, The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation, Gene Expr, 5, 245
Mariadason, 2000, Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer, Cancer Res, 60, 4561
Yang, 2001, Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway, J. Biol. Chem, 276, 25742, 10.1074/jbc.M102821200
Siavoshian, 2000, Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression, Gut, 46, 507, 10.1136/gut.46.4.507
Tran, 1998, Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells, Am. J. Physiol. Gastrointest. Liver Physiol, 275, G85, 10.1152/ajpgi.1998.275.1.G85
Lu, 1999, Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells, Biochim. Biophys. Acta, 1444, 85, 10.1016/S0167-4781(98)00257-7
Walker, 2001, Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex, Endocrinology, 142, 3817, 10.1210/endo.142.9.8380
Mastrangelo, 1991, DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement, Proc. Natl. Acad. Sci. U.S.A, 88, 5670, 10.1073/pnas.88.13.5670
Pascal, 1991, Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism, Genes Dev, 5, 1646, 10.1101/gad.5.9.1646
Ryu, 1999, The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1, Nature, 397, 446, 10.1038/17141
Doetzlhofer, 1999, Histone deacetylase 1 can repress transcription by binding to Sp1, Mol. Cell. Biol, 19, 5504, 10.1128/MCB.19.8.5504
Xiao, 2000, p300 collaborates with Sp1 and Sp3 in p21waf1/cip1 promoter activation induced by histone deacetylase inhibitor, J. Biol. Chem, 275, 1371, 10.1074/jbc.275.2.1371
Porter, 1997, Functional synergy between the transcription factor Sp1 and the estrogen receptor, Mol. Endocrinol, 11, 1569, 10.1210/mend.11.11.9916
Kennett, 1997, Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription, Nucleic Acids Res, 25, 3110, 10.1093/nar/25.15.3110
Philipsen, 1999, A tale of three fingers: the family of mammalian Sp/XKLF transcription factors, Nucleic Acids Res, 27, 2991, 10.1093/nar/27.15.2991
Tsai, 2002, Regulation of histone deacetylase 2 by protein kinase CK2, J. Biol. Chem, 277, 31826, 10.1074/jbc.M204149200
Niefind, 2001, Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme, EMBO J, 20, 5320, 10.1093/emboj/20.19.5320
Landesman-Bollag, 2001, Protein kinase CK2: signaling and tumorigenesis in the mammary gland, Mol. Cell. Biochem, 227, 153, 10.1023/A:1013108822847
Landesman-Bollag, 2001, Protein kinase CK2 in mammary gland tumorigenesis, Oncogene, 20, 3247, 10.1038/sj.onc.1204411
Tawfic, 2001, Protein kinase CK2 signal in neoplasia, Histol. Histopathol, 16, 573
Pflum, 2001, Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation, J. Biol. Chem, 276, 47733, 10.1074/jbc.M105590200
Sowa, 1999, Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor, Cancer Res, 59, 4266
Bai, 2000, Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells, J. Biol. Chem, 275, 30725, 10.1074/jbc.M004249200
Richon, 2000, Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation, Proc. Natl. Acad. Sci. U.S.A, 97, 10014, 10.1073/pnas.180316197
Bottazzi, 1999, Regulation of p21cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase, J. Cell Biol, 146, 1255, 10.1083/jcb.146.6.1255
Cheng, 1999, The p21Cip1 and p27Kip1 CDK “inhibitors” are essential activators of cyclin D-dependent kinases in murine fibroblasts, EMBO J, 18, 1571, 10.1093/emboj/18.6.1571
Assoian, 1997, Anchorage-dependent cell cycle progression, J. Cell Biol, 136, 1, 10.1083/jcb.136.1.1
Roovers, 2000, Integrating the MAP kinase signal into the G1 phase cell cycle machinery, Bioessays, 22, 818, 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6
Nakano, 1997, Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line, J. Biol. Chem, 272, 22199, 10.1074/jbc.272.35.22199
Butler, 2001, Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase, Clin. Cancer Res, 7, 962
Marks, 2001, Inhibitors of histone deacetylase are potentially effective anticancer agents, Clin. Cancer Res, 7, 759
Richon, 2001, Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers, Blood Cells Mol. Dis, 27, 260, 10.1006/bcmd.2000.0376
Marks, 2000, Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells, J. Natl. Cancer Inst, 92, 1210, 10.1093/jnci/92.15.1210
Warrell, 1998, Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase, J. Natl. Cancer Inst, 90, 1621, 10.1093/jnci/90.21.1621
He, 2001, Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia, J. Clin. Invest, 108, 1321, 10.1172/JCI200111537